REGENXBIO

-$0.09 (-0.24%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell REGENXBIO and other stocks, options, and ETFs commission-free!

About RGNX

REGENXBIO Inc. Common Stock, also called REGENXBIO, is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy.

CEO
Kenneth T. Mills
Employees
306
Headquarters
Rockville, Maryland
Founded
2008

RGNX Key Statistics

Market Cap
1.60B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
301.74K
High Today
$37.89
Low Today
$37.22
Open Price
$37.83
Volume
128.18K
52 Week High
$50.26
52 Week Low
$25.93

RGNX Earnings

-$1.28
-$0.78
-$0.27
$0.23
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure